EDGAR Filing Documents for 0001493152-17-005352

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-17-005352

Filing Date

2017-05-15

Accepted

2017-05-15 16:59:29

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm	10-Q	889496
2		image_001.jpg	GRAPHIC	49067
3		ex31-1.htm	EX-31.1	18048
4		ex31-2.htm	EX-31.2	17975
5		ex32-1.htm	EX-32.1	7116
6		ex32-2.htm	EX-32.2	7087
	Complete submission text file	0001493152-17-005352.txt		4948574

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE FILE	aker-20170331.xml	EX-101.INS	823834
8	XBRL SCHEMA FILE	aker-20170331.xsd	EX-101.SCH	65638
9	XBRL CALCULATION FILE	aker-20170331_cal.xml	EX-101.CAL	68716
10	XBRL DEFINITION FILE	aker-20170331_def.xml	EX-101.DEF	225060
11	XBRL LABEL FILE	aker-20170331_lab.xml	EX-101.LAB	412897
12	XBRL PRESENTATION FILE	aker-20170331_pre.xml	EX-101.PRE	343028

Mailing Address 201 GROVE RD THOROFARE NJ 08086

Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698

Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)